Pathophysiology during neural information processing in ADHD
- Conditions
- F90Hyperkinetic disorders
- Registration Number
- DRKS00014922
- Lead Sponsor
- Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Amendment 1+2:
1) Age 18-45
2) Sufficient understanding of the German language for the questionnaire survey
3) Written informed consent of patients
4) Diagnosis of ADHD according to ICD-10
5) Clinically indicated treatment with methylphenidate
6) Stable psychotropic medication (except ADHD medication) for at least 4 weeks
Amendment 1:
unmedicated, concerning methylphenidate
Amendment 2:
Medicated for at least 6 months with methylphenidate
1. known neurological disorders affecting the brain, including condition after craniocerebral trauma with unconsciousness greater than 5 minutes
2. harmful substance use according to ICD-10
3. taking antipsychotics up to 4 weeks before baseline and during the examination period
For Amendment 1:
4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extended release) or within 48 hours (extended release and atomoxetine) before baseline
For Amendment 2:
4. taking pharmaceuticals for ADHD treatment on the day of the examination (not extemded release) or within 48 hours (extended release and atomoxetine) before baseline, with the exception of methylphenidate
5. motor hyperactivity at the time of measurement that makes an EEG examination impossible
6. known IQ < 70
7. premature birth < 32 wks
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evidence of specific changes in the EEG relative to medication
- Secondary Outcome Measures
Name Time Method Relationship between EEG parameters, dosage of medication, neuropsychology and interviews on the current condition (ADHS-E, Wender Utah Rating Scale short form (WURS-K), Wender-Reimherr-Interview (WRI-V), Testbatterie zur Aufmerksamkeitsprüfung (TAP))